Pharmacological management of testosterone deficiency in men current advances and future directions.

Testosterone deficiency affects approximately 2% of the general male population and is relatively common in aging men.

• Prevalence estimated at around 2% of the general population
• Condition is associated with aging in men
• Testosterone replacement therapy (TRT) is the most common medical approach for subjects not interested in fathering

Several new TRT formulations have been introduced to the market during the last decade, including oral, transdermal, and parenteral formulations.

• New formulations introduced over the past decade span multiple delivery routes: oral, transdermal, and parenteral
• Both approved and non-approved pharmacological options exist to overcome testosterone deficiency
• Possible advantages and limitations of each formulation were discussed

Anti-estrogens, including selective estrogen receptor modulators (SERMs) and aromatase inhibitors, remain off-label options for testosterone deficiency but carry significant limitations.

• Both selective estrogen modulators and aromatase inhibitors are classified as off-label options
• Long-term side effects on sexual function constitute a major limitation of anti-estrogen therapy
• Long-term side effects on bone parameters also constitute a major limitation
• These agents are described as 'further possible off-label options'

Glucagon-like peptide-1 (GLP-1) analogues represent an alternative treatment option for testosterone deficiency, particularly in cases of massive obesity-associated testosterone deficiency.

• GLP-1 analogues are specifically indicated as an alternative for 'massive obesity-associated TD'
• This approach is positioned as an alternative rather than a primary option
• The utility is framed within the context of obesity-driven testosterone deficiency

Weight loss through lifestyle modifications including diet and physical exercise should be encouraged in all overweight and obese patients with testosterone deficiency.

• Lifestyle modifications encompass both dietary changes and physical exercise
• Recommendation applies broadly to 'all overweight and obese patients'
• A combination of TRT and lifestyle changes can be considered when reversal of the condition cannot be expected in a reasonable time frame

A meta-analytic approach was applied where possible to minimize subjective and biased interpretations of available data on testosterone deficiency treatments.

• Authors explicitly state that 'when possible, a meta-analytic approach was applied to minimize subjective and biased interpretations of the available data'
• This methodological approach was used across the review of pharmacological options
• The approach was applied to available published data rather than new primary data collection